http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102603737-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53b4d53983adbf56dd0e7d0bf96f8ce5
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
filingDate 2012-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_314af53f9b56ebdd3260da47f71130f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e7ad2928f7b5b825657c0cfe42a7500
publicationDate 2014-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102603737-B
titleOfInvention Pyridopyrimidine ketones derivative and application in preparing antitumor drugs thereof
abstract The invention relates to pyridopyrimidine ketones derivatives and application of the pyridopyrimidine ketones derivatives in preparing antitumor drugs, belongs to the chemical pharmaceutical area, particularly relates to application of a compound with a structure shows as formula (I), wherein Ar represents a substituted benzene ring or a heterocyclic ring Het; R1 represents H or CH3; and R2 represents a substituted benzene ring, a heterocyclic ring or alkane. Experiments show that compound with a structure shown as formula (I) has varying degrees of inhibitory activity in vitro to A549 (human lung adenocarcinoma cell), HepG2 (human hepatocellullar carcinoma cell), SKOV-3 (human ovarian neoplasm), Hela (human cervical carcinoma cell) and SW620 (human colonic cancer cell), and in particular has good inhibitory activity to SW620, so that a new choice is provided for preparation of the antitumor drugs.
priorityDate 2012-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009080198-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465994468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11083966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453947315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467766942
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59922646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467013490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393629
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70120
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415745261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420228224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467971107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449495704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424488051
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21558952
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6321432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421359242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10313094

Total number of triples: 40.